MNPR - Balance Sheet - Monopar Therapeutics Inc.

Current Liabilities	5.25 B
Accounts Payable	2.25 M
Short-Term Debt	0
Other Current Liabilities	5.25 B
Non-Current Liabilities	0
Long-Term Debt	0
Other Non-Current Liabilities	0

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016	Dec-2015
ASSETS
Cash & Cash Equivalents	45.8	7.3	8.2	20.3	16.7	13.2	6.9	9.0	2.1	2.0
Short Term Investments	14.4	0	4.9	0	0	0	0	0	0	0
Receivables	0	0	0	0	0	0	0	0	0	0
Inventory	0	0	0	0	0	0	0	0	0	0
Other Current Assets	0	66.4 K	46 K	0.2	62.7 K	15.7 K	0.4	0.1	22.6 K	22.9 K
Total Current Assets	60.3	7.3	13.2	20.5	16.8	13.2	7.3	9.1	2.1	2.0
PP&E	0	12.6 K	61.2 K	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0	0	0.8	0.8	0.8
Other Long Term Assets	0	0	0	0	68.9 K	0.1	0.4	0	0	0
Other Assets	0	0	0	0	0	0	(0.4)	0	0	0
Total Assets	60.3	7.3	13.2	20.5	16.9	13.4	7.3	9.9	2.9	2.8
LIABILITIES
Accounts Payable	2.3	1.8	3.1	1.6	1.2	0.7	0.4	0.3	64.5 K	73.8 K
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	5 252.0	0	0	0	0	0	0	0	0	0
Total Current Liabilities	5 254.3	1.8	3.1	1.6	1.2	0.7	0.4	0.3	64.5 K	73.8 K
Long Term Debt	0	0	8.41 K	0	0	0	0	0	0	0
Deferred Tax Income	0	0	0	0	0	0	0	0	0	0
Other Liabilities	0	0	0	0	0	0	0	0	0	0
Total Liabilities	5.3	1.8	3.1	1.6	1.2	0.7	0.4	0.3	64.5 K	73.8 K
EQUITY
Common Stock	6.1 K	14.9 K	12.9 K	12.6 K	11.5 K	10.6 K	9.29 K	9.29 K	0	0
Retained Earnings	(75 792.6)	(60.2)	(51.8)	(41.3)	(32.2)	(25.9)	(21.7)	(18.4)	(1.9)	(0.7)
Other Accumulative Comprehensive Income/Loss	36 K	14.1 K	8.94 K	3.16 K	7.87 K	11 K	2.4 K	0	0	0
Total Equity	55 036.8	5.6	10.1	18.9	15.7	12.6	6.9	9.6	2.8	2.8
Total Liabilities and Equity	60.3	7.3	13.2	20.5	16.9	13.4	7.3	9.9	2.9	2.8
SHARES OUTSTANDING
Common Shares Outstanding	37.9	14.5	12.7	12.5	11.0	10.6	10.4	10.4	10.4	10.6

Free